Cargando…

Homocysteine metabolism as the target for predictive medical approach, disease prevention, prognosis, and treatments tailored to the person

Homocysteine (Hcy) metabolism is crucial for regulating methionine availability, protein homeostasis, and DNA-methylation presenting, therefore, key pathways in post-genomic and epigenetic regulation mechanisms. Consequently, impaired Hcy metabolism leading to elevated concentrations of Hcy in the b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koklesova, Lenka, Mazurakova, Alena, Samec, Marek, Biringer, Kamil, Samuel, Samson Mathews, Büsselberg, Dietrich, Kubatka, Peter, Golubnitschaja, Olga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581606/ https://www.ncbi.nlm.nih.gov/pubmed/34786033 http://dx.doi.org/10.1007/s13167-021-00263-0

Ejemplares similares

Mitochondrial health quality control: measurements and interpretation in the framework of predictive, preventive, and personalized medicine
por: Koklesova, Lenka, et al.
Publicado: (2022)

Phytochemical-based nanodrugs going beyond the state-of-the-art in cancer management—Targeting cancer stem cells in the framework of predictive, preventive, personalized medicine
por: Koklesova, Lenka, et al.
Publicado: (2023)

Anti-prostate cancer protection and therapy in the framework of predictive, preventive and personalised medicine — comprehensive effects of phytochemicals in primary, secondary and tertiary care
por: Mazurakova, Alena, et al.
Publicado: (2022)

Therapy-resistant breast cancer in focus: Clinically relevant mitigation by flavonoids targeting cancer stem cells
por: Mazurakova, Alena, et al.
Publicado: (2023)

Antithrombotic and antiplatelet effects of plant-derived compounds: a great utility potential for primary, secondary, and tertiary care in the framework of 3P medicine
por: Kubatka, Peter, et al.
Publicado: (2022)

Flavonoids against non-physiologic inflammation attributed to cancer initiation, development, and progression—3PM pathways
por: Kubatka, Peter, et al.
Publicado: (2021)

Mitochondriopathies as a Clue to Systemic Disorders—Analytical Tools and Mitigating Measures in Context of Predictive, Preventive, and Personalized (3P) Medicine
por: Liskova, Alena, et al.
Publicado: (2021)

Flavonoids Synergistically Enhance the Anti-Glioblastoma Effects of Chemotherapeutic Drugs
por: Zhai, Kevin, et al.
Publicado: (2021)

Protective Effects of Flavonoids Against Mitochondriopathies and Associated Pathologies: Focus on the Predictive Approach and Personalized Prevention
por: Koklesova, Lenka, et al.
Publicado: (2021)

Carotenoids in Cancer Metastasis—Status Quo and Outlook
por: Koklesova, Lenka, et al.
Publicado: (2020)

Metabolic Anti-Cancer Effects of Melatonin: Clinically Relevant Prospects
por: Samec, Marek, et al.
Publicado: (2021)

Carotenoids in Cancer Apoptosis—The Road from Bench to Bedside and Back
por: Koklesova, Lenka, et al.
Publicado: (2020)

Anti-breast cancer effects of phytochemicals: primary, secondary, and tertiary care
por: Mazurakova, Alena, et al.
Publicado: (2022)

Flavonoids in Cancer Metastasis
por: Liskova, Alena, et al.
Publicado: (2020)

Targeting phytoprotection in the COVID-19-induced lung damage and associated systemic effects—the evidence-based 3PM proposition to mitigate individual risks
por: Liskova, Alena, et al.
Publicado: (2021)

Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem Cells
por: Samuel, Samson Mathews, et al.
Publicado: (2020)

Liquid Biopsy is Instrumental for 3PM Dimensional Solutions in Cancer Management
por: Liskova, Alena, et al.
Publicado: (2020)

Mitochondrial impairments in aetiopathology of multifactorial diseases: common origin but individual outcomes in context of 3P medicine
por: Koklesova, Lenka, et al.
Publicado: (2021)

Targeting Glucose Metabolism to Overcome Resistance to Anticancer Chemotherapy in Breast Cancer
por: Varghese, Elizabeth, et al.
Publicado: (2020)

miRNA Expression Profiles in Luminal A Breast Cancer—Implications in Biology, Prognosis, and Prediction of Response to Hormonal Treatment
por: Kudela, Erik, et al.
Publicado: (2020)

Cell-free nucleic acid patterns in disease prediction and monitoring—hype or hope?
por: Crigna, Adriana Torres, et al.
Publicado: (2020)

Flavonoids against the Warburg phenotype—concepts of predictive, preventive and personalised medicine to cut the Gordian knot of cancer cell metabolism
por: Samec, Marek, et al.
Publicado: (2020)

Genoprotective activities of plant natural substances in cancer and chemopreventive strategies in the context of 3P medicine
por: Koklesova, Lenka, et al.
Publicado: (2020)

Underexplored reciprocity between genome-wide methylation status and long non-coding RNA expression reflected in breast cancer research: potential impacts for the disease management in the framework of 3P medicine
por: Kapinova, Andrea, et al.
Publicado: (2023)

Fluctuations of Histone Chemical Modifications in Breast, Prostate, and Colorectal Cancer: An Implication of Phytochemicals as Defenders of Chromatin Equilibrium
por: Samec, Marek, et al.
Publicado: (2019)

Flavonoids as an effective sensitizer for anti-cancer therapy: insights into multi-faceted mechanisms and applicability towards individualized patient profiles
por: Liskova, Alena, et al.
Publicado: (2021)

Pre-pregnancy check-up of maternal vascular status and associated phenotype is crucial for the health of mother and offspring
por: Evsevieva, Maria, et al.
Publicado: (2022)

Caution, “normal” BMI: health risks associated with potentially masked individual underweight—EPMA Position Paper 2021
por: Golubnitschaja, Olga, et al.
Publicado: (2021)

Systemic Effects Reflected in Specific Biomarker Patterns Are Instrumental for the Paradigm Change in Prostate Cancer Management: A Strategic Paper
por: Golubnitschaja, Olga, et al.
Publicado: (2022)

Flavonoids’ Dual Benefits in Gastrointestinal Cancer and Diabetes: A Potential Treatment on the Horizon?
por: AL-Ishaq, Raghad Khalid, et al.
Publicado: (2022)

Rho GTPases in Gynecologic Cancers: In-Depth Analysis toward the Paradigm Change from Reactive to Predictive, Preventive, and Personalized Medical Approach Benefiting the Patient and Healthcare
por: Zubor, Pavol, et al.
Publicado: (2020)

Immunomodulation by Gut Microbiome on Gastrointestinal Cancers: Focusing on Colorectal Cancer
por: AL-Ishaq, Raghad Khalid, et al.
Publicado: (2022)

Treating Cancers Using Nature’s Medicine: Significance and Challenges
por: Samuel, Samson Mathews, et al.
Publicado: (2021)

Anti-Angiogenic Effects of Phytochemicals on miRNA Regulating Breast Cancer Progression
por: Varghese, Elizabeth, et al.
Publicado: (2020)

Diabetes and coronavirus (SARS-CoV-2): Molecular mechanism of Metformin intervention and the scientific basis of drug repurposing
por: Varghese, Elizabeth, et al.
Publicado: (2021)

Dietary Phytochemicals Targeting Cancer Stem Cells
por: Liskova, Alena, et al.
Publicado: (2019)

Cold Atmospheric Pressure Plasma (CAP) as a New Tool for the Management of Vulva Cancer and Vulvar Premalignant Lesions in Gynaecological Oncology
por: Zubor, Pavol, et al.
Publicado: (2020)

Paclitaxel’s Mechanistic and Clinical Effects on Breast Cancer
por: Abu Samaan, Tala M., et al.
Publicado: (2019)

Anticancer Potential of Lichens’ Secondary Metabolites
por: Solárová, Zuzana, et al.
Publicado: (2020)

Tirzepatide—Friend or Foe in Diabetic Cancer Patients?
por: Samuel, Samson Mathews, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k00rul8t03pki48u74gt0kee3s